Literature DB >> 3594659

Effects of albumin and alpha 1-acid glycoprotein on the transport of imipramine and desipramine through the blood-brain barrier in rats.

T H Lin, Y Sawada, Y Sugiyama, T Iga, M Hanano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3594659     DOI: 10.1248/cpb.35.294

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  6 in total

Review 1.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Effects of 5'-ester modification on the physicochemical properties and plasma protein binding of 5-iodo-2'-deoxyuridine.

Authors:  M K Ghosh; A K Mitra
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

3.  Kinetic analysis of albumin-mediated uptake of warfarin by perfused rat liver.

Authors:  S C Tsao; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1988-04

Review 4.  Biological barriers, and the influence of protein binding on the passage of drugs across them.

Authors:  Karolina Wanat
Journal:  Mol Biol Rep       Date:  2020-03-05       Impact factor: 2.316

Review 5.  Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling.

Authors:  Elizabeth C M de Lange; Paulien G M Ravenstijn; Dorien Groenendaal; Tamara J van Steeg
Journal:  AAPS J       Date:  2005-10-07       Impact factor: 4.009

6.  Measurement of drug-protein dissociation rates by high-performance affinity chromatography and peak profiling.

Authors:  John E Schiel; Corey M Ohnmacht; David S Hage
Journal:  Anal Chem       Date:  2009-06-01       Impact factor: 6.986

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.